Related Experiment Video
Updated: May 4, 2026
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
A multicenter-validated interpretable transformer model for pituitary microadenoma detection on non-contrast
Siru Kang1,2,3, Wenxia Yang1,2,3, Yijun Yu4
1Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, No. 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Background:
Detecting pituitary microadenomas using non-contrast multi-parametric magnetic resonance imaging (MRI) is challenging yet essential for clinical decisions. This study aimed to develop a transformer deep learning (DL) model for detecting pituitary microadenomas based on non-contrast multiparametric MRI and explore the explainability techniques to enhance transparency in convolutional neural network (CNN)-based classification. The primary research question addressed is how to improve the accuracy, generalization, and interpretability of CNNs for microadenomas detection.
Methods:
Non-contrast multiparametric MRI sella area scans of 590 patients were retrospectively collected from three hospitals. The development and comparison of 2D_DL, 2.5D_DL, 2D_multichannel, and transformer models for classification. By incorporating Explainable AI (XAI), including Gradient-weighted Class Activation Mapping(Grad-CAM) and SHapley Additive exPlanations (SHAP), we improve model interpretability.
Results:
The performance of the 2D_multichannel model, with an area under the curve (AUC) of 0.893, was better to that of the 2D_T1SAG_DL, 2D_T1COR_DL, 2D_T2COR_DL (AUC, 0.884, 0.779, and 0.846, respectively). The performance of the transformer model, with an area under the curve (AUC) of 0.985, was superior to that of the 2.5D_T1SAG_DL, 2.5D_T1COR_DL, 2.5D_T2COR_DL (AUC, 0.763, 0.863, and 0.835, respectively). The non-contrast MRI-based 2.5D_DL transformer model all shows outperforming performance in the internal and two external test sets (AUC, 0.874, 0.829, and 0.819, respectively).
Conclusions:
Given its robust diagnostic performance and enhanced interpretability, this model demonstrates significant potential for clinical translation as a decision-support tool in the detection of pituitary microadenomas.
